ESC 365 - Characteristics and safety outcomes in first-time users of the P2Y12 receptor antagonists clopidogrel, prasugrel and ticagrelor

ESC Premium Access

Characteristics and safety outcomes in first-time users of the P2Y12 receptor antagonists clopidogrel, prasugrel and ticagrelor

Session: Poster session 2 - Clinical platelet studies

Topic: Thrombosis and platelets

Speaker: Associate Professor S. Johansson (Molndal, SE)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Associate Professor Saga Johansson

Molndal (Sweden)

0 follower

24 more presentations in this session

Effect of pretreatment with P2Y12 receptor antagonists on mortality in patients undergoing PCI: A report from SCAAR

Speaker: Professor E. Omerovic (Gothenburg, SE)

Gender differences in oral antiplatelet treatment use - results from a nationwide cohort study of acute coronary syndrome patients in Finland

Speaker: Doctor V. Kyto (Turku, FI)

Prevalence and outcomes of prasugrel versus clopidogrel in patients with and without diabetes following percutaneous coronary intervention for acute coronary syndrome

Speaker: Doctor M. Faggioni (Philadelphia, US)

Platelet reactivity and outcomes after transcatheter aortic valve implantation

Speaker: Doctor L. Gross (Munich, DE)

Safety of a regional standardized protocol to optimize the use of most effective platelet inhibition in ACS treated with PCI : Final Results from the Multicenter Rijnmond Collective Cardiology Study

Speaker: Doctor M. Van Der Linden (Schiedam, NL)

Access the full session

Poster session 2 - Clinical platelet studies

Speakers: Associate Professor S. Johansson, Professor E. Omerovic, Doctor V. Kyto, Doctor M. Faggioni, Doctor L. Gross...

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources